A new study has demonstrated that women may only need three cervical screens in their lifetime if they have received the HPV vaccine.
Browsing: Disease Area > Gynecologic
Among other criteria, in this research article from Future Science OA, the authors validated the Gynecological Cancer Intergroup CA125 progression criteria in an ovarian cancer population regarding sensitivity, specificity, positive predictive value and negative predictive value.
In this perspective paper, discover three pictorial models that are designed to help offer patients focus and belief when combating cancer in their lives to allow them to embrace hope with greater confidence, which minimizes their grief.
This article reviews progress made in the creation of a transplantable artificial ovary and discusses future trends for its development.
In 2017, every woman in Australia aged 37 years and younger is already better protected against HPV than ever before – this is a huge milestone and a truly remarkable feat. How was this achieved and what hurdles still exist? Find out in this exclusive opinion piece.
New findings suggest that women who receive human papillomavirus (HPV) testing as well as a Pap smear obtain a faster and more complete diagnosis of cervical disease.
In this editorial from Future Oncology the different types of endometrial cancer are appraised.
In this review article from Future Oncology the authors highlight why we may need to reconsider the grading of cervical intraepithelial neoplasia.
Findings from the largest group of men treated for penile cancer by a single institution have demonstrated the benefits of brachytherapy.